FTL and neuroferritinopathy: Supported by the clinical manifestations found in this family (low serum ferritin levels, low transferrin saturation and lack of serious neurological or movement abnormalities), the molecular mechanism in this case is most probably due to the loss of function of FTL and it will be not expected that the disease derives in neuroferritinopathy.